Septodont Holding Drug Patent Portfolio
Septodont Holding owns 1 orange book drug protected by 5 US patents Given below is the list of Septodont Holding's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7575757 | Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof | 21 Apr, 2025 | Active |
| US7569230 | Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof | 17 Oct, 2023 | Expired |
| US7229630 | Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof | 20 Jun, 2023 | Expired |
| US6764678 | Local anesthetic methods and kits | 11 May, 2021 | Expired |
| US6872390 | Local anesthetic methods and kits | 11 May, 2021 | Expired |
Latest Legal Activities on Septodont Holding's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Septodont Holding.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 08 Feb, 2021 | US7575757 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 25 Jan, 2021 | US7569230 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 03 Dec, 2018 | US7229630 |
| Request for Trial Granted in Part | 06 Nov, 2016 | US7575757 |
| Petition Requesting Trial | 06 Nov, 2016 | US7575757 |
| Termination or Final Written Decision | 06 Nov, 2016 | US7575757 |
|
Request for Trial Granted
Critical
| 08 Jul, 2016 | US7575757 |
| Petition Requesting Trial | 08 Jul, 2016 | US7575757 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 30 Dec, 2010 | US7229630 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 18 Aug, 2009 | US7575757 |
|
Recordation of Patent Grant Mailed
Critical
| 18 Aug, 2009 | US7575757 |
|
Recordation of Patent Grant Mailed
Critical
| 04 Aug, 2009 | US7569230 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 04 Aug, 2009 | US7569230 |
|
Issue Notification Mailed
Critical
| 29 Jul, 2009 | US7575757 |
|
Issue Notification Mailed
Critical
| 15 Jul, 2009 | US7569230 |
Septodont Holding's Family Patents
Septodont Holding Drug List
Given below is the complete list of Septodont Holding's drugs and the patents protecting them.
1. Oraverse
Oraverse is protected by 5 patents, out of which 4 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7575757 | Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof |
21 Apr, 2025
(3 months from now)
| Active |
| US7569230 | Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof |
17 Oct, 2023
(1 year, 2 months ago)
| Expired |
| US7229630 | Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof |
20 Jun, 2023
(1 year, 6 months ago)
| Expired |
| US6764678 | Local anesthetic methods and kits |
11 May, 2021
(3 years ago)
| Expired |
| US6872390 | Local anesthetic methods and kits |
11 May, 2021
(3 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Oraverse's drug page